Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00561379
What this trial is testing

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

Who this might be right for
Lymphoma, Large-Cell, Diffuse
Nantes University Hospital 350
Testing effectiveness (Phase 2)Study completedNCT01389427
What this trial is testing

Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL).

Who this might be right for
Mantle Cell Lymphoma Refractory
The Lymphoma Academic Research Organisation 41
Testing effectiveness (Phase 2)Study completedNCT02441803
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT00002436
What this trial is testing

The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT

Who this might be right for
HIV Infections
Glaxo Wellcome 325
Testing effectiveness (Phase 2)Study completedNCT00255723
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 98
Not applicableStudy completedNCT05250661
What this trial is testing

Efficacy of Propolis in the Prevention of Oral Mucositis

Who this might be right for
Oral Mucositis
Karadeniz Technical University 64
Testing effectiveness (Phase 2)Study completedNCT00143871
What this trial is testing

Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin's
University of Michigan Rogel Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT03490344
What this trial is testing

Short Course Daratumumab in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT00001507
What this trial is testing

Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer

Who this might be right for
Breast NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 107
Large-scale testing (Phase 3)WithdrawnNCT07428369
What this trial is testing

Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma (MM)
Regeneron Pharmaceuticals
Not applicableEnded earlyNCT01541072
What this trial is testing

Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation

Who this might be right for
Non Hodgkin Lymphoma
Centre Leon Berard 34
Large-scale testing (Phase 3)UnknownNCT00003578
What this trial is testing

High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Lymphoma Trials Office 500
Early research (Phase 1)Looking for participantsNCT05865535
What this trial is testing

A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia

Who this might be right for
Cachexia
AVEO Pharmaceuticals, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT02573935
What this trial is testing

Clarithromycin in Multiple Myeloma Induction Therapy

Who this might be right for
Multiple Myeloma
Henrik Gregersen 58
Large-scale testing (Phase 3)Study completedNCT01034163
What this trial is testing

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin's Lymphoma
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT06812871
What this trial is testing

High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT03330821
What this trial is testing

Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Myelodysplasia-Related ChangesTherapy-Related Acute Myeloid Leukemia
University of Southern California 53
Testing effectiveness (Phase 2)Study completedNCT00144092
What this trial is testing

HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Who this might be right for
Low Grade Lymphoma
Alberta Health services 60
Large-scale testing (Phase 3)Study completedNCT00205764
What this trial is testing

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 212
Not applicableStudy completedNCT03054883
What this trial is testing

Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy

Who this might be right for
Mantle Cell Lymphoma
Czech Lymphoma Study Group 73
Next Page